Winship Cancer Institute of Emory University received $7.8 million from the Paula and Rodger Riney Foundation to fund the Riney Family Multiple Myeloma Research Program Fund.
Ge Jin and Bingcheng Wang received a $3.7 million five-year grant to explore why those living with HIV have a higher risk for certain kinds of cancers, such as lung cancer.
The Prostate Cancer Foundation and Robert F. Smith, founder, chairman and CEO of Vista Equity Partners, plan to collaborate on research to reduce deaths from prostate cancer.
In a July 24, 2020 letter to the editor entitled, “Insurers’ moves to limit telehealth amid COVID-19 are inhumane and must be stopped,” the authors use disjointed logic to reach an inaccurate conclusion.
The Senate appropriations subcommittee July 27 proposed a fifth COVID-19 pandemic relief package that includes $15.5 billion in supplemental funds for NIH.
Two articles in the July 24 issue of The Cancer Letter referenced a April 1 Journal of Urology manuscript (doi:10.1097/JU.0000000000000577) describing frequent delays in administration of LHRH agonists and the potential clinical impact as assessed through recovery of testosterone.
Raymond N. DuBois was named director of MUSC Hollings Cancer Center effective Aug. 17.
A UC Davis cancer researcher was arrested July 24 on visa fraud charges.
Stephen Nimer: Cancer patients are coming in for treatment, Florida’s COVID-19 spike notwithstanding
“Our chemotherapy and radiation therapy volumes have been very robust. Probably because of the NCI designation, we are seeing significantly more patients than last year,” Stephen D. Nimer, director of Sylvester Comprehensive Cancer Center, said to The Cancer Letter. “Compared to last year, we seem to be up about 15%. We’ve been growing by about 8% to 9% for quite some years. This year is even more.”
The past two decades have brought hope to myeloma patients, as the majority benefit from the significant advances in chemotherapy.
